Akiko Watanabe, PhD (she/her/hers)

Director
Daiichi Sankyo Co., Ltd., Japan

Poster(s):

• (S-064) Physiologically Based Pharmacokinetic Modeling of Quizartinib to Assess Drug-Drug Interaction as an Inhibitor of Breast Cancer Resistance Protein
  Sunday, October 19, 2025

  7:00 AM - 5:00 PM MDT